financetom
Business
financetom
/
Business
/
Campbell's Faces Pressure Ahead of Fiscal Q1 Results as Snacking Weakness, Competition Dampen Outlook, RBC Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Campbell's Faces Pressure Ahead of Fiscal Q1 Results as Snacking Weakness, Competition Dampen Outlook, RBC Says
Mar 10, 2026 9:49 PM

12:35 PM EST, 12/08/2025 (MT Newswires) -- Campbell's (CPB) remains under pressure ahead of its fiscal Q1 earnings as weakness in the snacking category and rising competition continue to weigh on expectations, RBC Capital Markets said in a report emailed Monday.

RBC analysts maintained their "negative" view on Campbell's, citing ongoing share losses, underperformance relative to peers, and a lack of clear catalysts for improvement despite the stock's inexpensive valuation, according to the report.

RBC noted stronger positioning in the meals and beverages segment as consumers shift toward value and at-home dining, and flagged potential near-term soup strength tied to pantry stocking ahead of expected Supplemental Nutrition Assistance Program benefit delays, though any benefit would likely reverse later, according to the report.

Campbell's is also navigating "higher input costs" heading into fiscal 2026 while trying to reinvest in marketing and innovation to revive key brands. The firm said pricing actions will be harder to take due to "consumer wallet

pressure," and additional spending may be needed if the snacking category does not improve in H2 of the fiscal year, the report said.

RBC has a sector perform rating on Campbell's, with a price target of $35.

Shares of the company were up 1.8% in recent Monday trading.

Price: 30.14, Change: +0.54, Percent Change: +1.82

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Forward Industries Agrees to Buy Back $27.4 Million of Shares
Forward Industries Agrees to Buy Back $27.4 Million of Shares
Mar 19, 2026
09:13 AM EDT, 03/19/2026 (MT Newswires) -- Forward Industries ( FWDI ) said Thursday it has agreed to buy back roughly 6.2 million common shares from an institutional investor for $27.4 million. The company said it obtained a $40 million loan from Galaxy Digital to finance the transaction as well as support its digital asset treasury strategy. In addition, Forward...
Why SoFi Technologies Stock Is Falling Thursday?
Why SoFi Technologies Stock Is Falling Thursday?
Mar 19, 2026
SoFi Technologies Inc ( SOFI ) shares are trading lower during Thursday's premarket session. The digital lender faces a combination of heavy short-seller allegations and broader market weakness. The decline follows a turbulent week for the fintech firm. Broad market indices are also under pressure. Nasdaq futures fell 0.71% Thursday morning. S&P 500 futures shed 0.59% in tandem. Muddy Waters...
Terreno Realty Corporation Sells Property in Gardena, CA for $44.0 Million
Terreno Realty Corporation Sells Property in Gardena, CA for $44.0 Million
Mar 19, 2026
BELLEVUE, Wash.--(BUSINESS WIRE)-- Terreno Realty Corporation ( TRNO ) , an acquirer, owner and operator of industrial real estate in six major coastal U.S. markets, sold an industrial property located in Gardena, California on March 18, 2026 for a sale price of approximately $44.0 million. The property consists of two industrial distribution buildings containing 231,000 square foot on 11.1 acres...
Biohaven Completes Enrollment for Phase 2 Obesity Study Evaluating Taldefgrobep Alfa
Biohaven Completes Enrollment for Phase 2 Obesity Study Evaluating Taldefgrobep Alfa
Mar 19, 2026
08:41 AM EDT, 03/19/2026 (MT Newswires) -- Biohaven ( BHVN ) said Thursday that it has completed enrollment for a phase 2 proof-of-concept study evaluating treatment with once-weekly and once-monthly taldefgrobep alfa in people living with obesity. The primary outcome measure of the study is percent change in total body weight from baseline to week 24, and secondary outcome measures...
Copyright 2023-2026 - www.financetom.com All Rights Reserved